Biosergen AB (BIOSGN.ST)

SEK 0.51

(-5.9%)

Operating Income Summary of Biosergen AB

  • Biosergen AB's latest annual operating income in 2023 was -27.26 Million SEK , up 20.11% from previous year.
  • Biosergen AB's latest quarterly operating income in 2024 Q2 was -5.72 Million SEK , up 15.74% from previous quarter.
  • Biosergen AB reported an annual operating income of -34.12 Million SEK in 2022, down -0.15% from previous year.
  • Biosergen AB reported an annual operating income of -34.07 Million SEK in 2021, down -447.35% from previous year.
  • Biosergen AB reported a quarterly operating income of -5.72 Million SEK for 2024 Q2, up 15.74% from previous quarter.
  • Biosergen AB reported a quarterly operating income of -8.03 Million SEK for 2023 Q2, down -59.83% from previous quarter.

Annual Operating Income Chart of Biosergen AB (2023 - 2019)

Historical Annual Operating Income of Biosergen AB (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -27.26 Million SEK 20.11%
2022 -34.12 Million SEK -0.15%
2021 -34.07 Million SEK -447.35%
2020 -6.22 Million SEK 4.49%
2019 -6.51 Million SEK 0.0%

Peer Operating Income Comparison of Biosergen AB

Name Operating Income Operating Income Difference
Alligator Bioscience AB (publ) -248.98 Million SEK 89.049%
Ziccum AB (publ) -21.56 Million SEK -26.461%
Modus Therapeutics Holding AB (publ) -16.4 Million SEK -66.24%
BioArctic AB (publ) 252.64 Million SEK 110.792%
Sprint Bioscience AB (publ) -845 Thousand SEK -3126.627%
Mendus AB (publ) -100.65 Million SEK 72.911%
Genovis AB (publ.) 54.22 Million SEK 150.282%
Intervacc AB (publ) -93.57 Million SEK 70.864%
QuiaPEG Pharmaceuticals Holding AB (publ) -15.51 Million SEK -75.767%
Active Biotech AB (publ) -46.48 Million SEK 41.345%
Magle Chemoswed Holding AB (publ) 18 Million SEK 251.397%
Bio-Works Technologies AB (publ) -55.41 Million SEK 50.8%
Aptahem AB (publ) -10.1 Million SEK -169.823%
Vicore Pharma Holding AB (publ) -321.5 Million SEK 91.52%
Kancera AB (publ) -65.04 Million SEK 58.081%
Infant Bacterial Therapeutics AB (publ) -134.61 Million SEK 79.746%
Fluicell AB (publ) -26.87 Million SEK -1.436%
Saniona AB (publ) -81.06 Million SEK 66.366%
Lipigon Pharmaceuticals AB (publ) -12.37 Million SEK -120.394%
Biovica International AB (publ) -126.07 Million SEK 78.374%
Spago Nanomedical AB (publ) -42.5 Million SEK 35.855%
AcouSort AB (publ) -17.48 Million SEK -55.916%
Xintela AB (publ) -57.23 Million SEK 52.366%
Abliva AB (publ) -96.54 Million SEK 71.76%
Egetis Therapeutics AB (publ) -324.8 Million SEK 91.606%
Karolinska Development AB (publ) -3.5 Million SEK -677.889%
OncoZenge AB (publ) -15.9 Million SEK -71.456%
Amniotics AB (publ) -29.07 Million SEK 6.219%
2cureX AB (publ) -36.36 Million SEK 25.02%
CombiGene AB (publ) -36.3 Million SEK 24.9%
Asarina Pharma AB (publ) -14.64 Million SEK -86.236%
Calliditas Therapeutics AB (publ) -384.39 Million SEK 92.907%
Camurus AB (publ) 532.35 Million SEK 105.122%
Corline Biomedical AB -1.78 Million SEK -1424.888%
IRLAB Therapeutics AB (publ) -180.76 Million SEK 84.917%
Isofol Medical AB (publ) -41.68 Million SEK 34.59%
I-Tech AB 24.43 Million SEK 211.582%
Hansa Biopharma AB (publ) -788.49 Million SEK 96.542%
Cyxone AB (publ) -21.66 Million SEK -25.871%
ExpreS2ion Biotech Holding AB (publ) -105.96 Million SEK 74.27%
Cantargia AB (publ) -290.01 Million SEK 90.599%
NextCell Pharma AB -43.17 Million SEK 36.846%
Xspray Pharma AB (publ) -180.76 Million SEK 84.917%
Elicera Therapeutics AB (publ) -17.09 Million SEK -59.479%
Nanologica AB (publ) -69.96 Million SEK 61.029%
SynAct Pharma AB -224.49 Million SEK 87.855%
Annexin Pharmaceuticals AB (publ) -44.17 Million SEK 38.281%
Stayble Therapeutics AB (publ) -23.95 Million SEK -13.821%
LIDDS AB (publ) -40.67 Million SEK 32.967%
Lipum AB (publ) -37.25 Million SEK 26.813%
BioInvent International AB (publ) -369.94 Million SEK 92.63%
Alzinova AB (publ) -16.52 Million SEK -65.022%
Oncopeptides AB (publ) -253.44 Million SEK 89.242%
Pila Pharma AB (publ) -6.39 Million SEK -326.465%
Guard Therapeutics International AB (publ) -115.07 Million SEK 76.306%
Scandinavian ChemoTech AB (publ) -20.13 Million SEK -35.384%
Simris Alg AB (publ) -36.63 Million SEK 25.577%
Diamyd Medical AB (publ) -146.56 Million SEK 81.398%
Xbrane Biopharma AB (publ) -310.42 Million SEK 91.217%
Ascelia Pharma AB (publ) -110.91 Million SEK 75.418%
Diagonal Bio AB (publ) -11.56 Million SEK -135.734%